• Chemtrade management commentary attributed third-quarter 2026 net earnings growth of CAD 5 million to CAD 47.3 million primarily to lower finance costs.
• Adjusted EBITDA fell 4% to CAD 145.1 million, driven by lower chlor-alkali selling prices, weaker sodium chlorate volumes and water-products margin pressure.
• Revenue rose 18.8% to CAD 633.1 million, supported by higher acid and sulphur selling prices alongside the Polytec acquisition.
• Polytec contributions, lower corporate costs and stronger sulphur-products earnings partially offset the adjusted EBITDA decline, management noted.
• For the first nine months of 2026, adjusted EBITDA fell 5.7% to CAD 385.9 million, partly reflecting North Vancouver maintenance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemtrade Logistics Income Fund published the original content used to generate this news brief on November 13, 2026, and is solely responsible for the information contained therein.